A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Clinical trial NCT06775379 · RECRUITING

Trial details

NCT number: NCT06775379
Sponsor: Xenon Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2024-12-20
Primary completion: 2026-08-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.